Statements, articles and media from the Director of the National Institutes of Health (NIH)
Updated: 40 weeks 4 days ago
It is with mixed emotions that I announce that Josie Briggs, M.D., will be retiring in October from the directorship of the National Center for Complementary and Integrative Health (NCCIH).
Clinical and research staff have embraced the pursuit of high reliability, and are focused on early recognition of potential problems and providing solutions for continuous improvement.
Drs. Collins and Wolinetz explain how NIH’s single IRB policy for multisite clinical research studies is complementary to the final Common Rule. The American Journal of Bioethics. Online: June 29, 2017.
Testimony on the Fiscal Year 2018 Budget Request before the Senate Committee.
Dr. Collins and researcher, surgeon & best-selling author Dr. Atul Gawande hosted a Facebook Live Q&A to talk about systems science & innovations in healthcare delivery.
President Trump intends to select Norman E. “Ned” Sharpless, M.D., as the new director of the National Cancer Institute (NCI).
In recognition of the call for such action in the 21st Century Cures Act, we are naming this effort the Next Generation Researchers Initiative.
As part of the NIH-Kennedy Center Sound Health Initiative, a series of workshops and performances focused on the connections between music, health/wellness, and science. STAT. June 6, 2017
Dr. Collins and renowned soprano Renée Fleming join NPR All Things Considered host Robert Siegel to discuss the partnership between the NIH and the John F. Kennedy Center for the Performing Arts called Sound Health to explore the effects of music on health and wellness and perform a duet.
Dr. Collins and Renée Fleming co-author an article in JAMA about the Sound Health: Music and the Mind initiative and the promise of music and music therapy for individual patients. JAMA. Online: June 2, 2017
In a co-authored NEJM Special Report, Dr. Collins and NIDA Director Dr. Nora Volkow outline a new public-private partnership initiative to address the opioid crisis. This new initiative will focus on three scientific areas: overdose-reversal and prevention interventions, new medications to treat opioid addiction, and non-addictive interventions for chronic pain. N Engl J Med. Online: May 31, 2017.
Dr. Johnson has been serving as the NIH Acting Deputy Director for Management since May 2016, and brings an incredible depth of NIH experience to this role.
Discussion on NIH’s diverse investments in biomedical research and some of the exciting scientific opportunities on the horizon, I want to thank this Subcommittee for your sustained commitment to NIH to ensure that our nation remains the global leader in the life sciences and advances in human health.
Today we want to put forward a new approach to making sure that we are exercising optimum stewardship of the funds that we receive from taxpayers.
As the largest public funder of clinical trials in the United States with an annual investment of about $3 billion, and in recognition of the dedicated research participants who volunteer their time and selves to forward medical progress, NIH takes its stewardship of our clinical trial enterprise very seriously.
Dr. Collins and Dr. Rubins hosted a Facebook Live Q&A on the benefits of conducting research at the International Space Station and the ongoing partnership between NIH and NASA. Dr. Rubins was the first person to sequence DNA in space.